Trial Profile
A randomized phase II study comparing single agent gemcitabine intravesical therapy versus mitomycin C in patients with intermediate risk superficial bladder cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 May 2007
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary) ; Mitomycin
- Indications Bladder cancer
- Focus Therapeutic Use
- 24 May 2007 Status change from in progress to completed.
- 02 Nov 2005 New trial record.